Riskpilot← Back to searchSign inGet full accessREDEFINE AS
ASActiveOrg 912154181Fürstveien 47B, 1367 SnarøyaOther human health activities n.e.c. · NACE 8699Est. 20131 employees
Revenue 2025
NOK 2M
+5% vs 2024
EBITDA margin
16.9%
-23% vs 2024
Equity ratio
74.3%
Financial strength
Net profit 2025
NOK 263K
-23% vs 2024
| Revenue | NOK 2M | +5% |
| EBITDA | NOK 339K | -23% |
| Net profit | NOK 263K | -23% |
| Total assets | NOK 1,4M | +16% |
| Equity | NOK 1M | +34% |
| Employees | 1 | — |
Legal name
REDEFINE AS
Org number
912154181
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
29. juni 2013
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Sykepleietjenester innenfor medisinsk kosmetikk og andre helsetjenester, samt virksomhet som hører inn under dette.
Address
Fürstveien 47B, 1367 Snarøya
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 648 | 2 471 | 2 238 | 1 913 | 2 012 |
| Staff expenses | −1 040 | −1 146 | −1 393 | −1 345 | −1 540 |
| EBITDA | 764 | 547 | 214 | 440 | 339 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 764 | 547 | 214 | 440 | 339 |
| Net financials | −0 | −1 | −3 | 0 | −2 |
| Profit before tax | 764 | 546 | 211 | 440 | 337 |
| Tax | 168 | 120 | 48 | 97 | 74 |
| Net profit | 596 | 426 | 162 | 342 | 263 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 275 | 1 252 | 1 144 | 1 215 | 1 409 |
| Equity | 253 | 279 | 442 | 784 | 1 047 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 022 | 972 | 702 | 431 | 362 |
| Total debt | 1 022 | 972 | 702 | 431 | 362 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20212025
Equity ratio
74.3%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
25.1%
This company
18.4%
Market median
+36% vs market
20212025
Net profit margin
13.1%
This company
8.1%
Market median
+62% vs market
20212025
Asset turnover
1.43×
This company
1.12×
Market median
+28% vs market
20212025
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KE Deputy Member | Deputy Member | 2013 |
PJ Chief Executive Officer | Chief Executive Officer | 2013 |
| Former (1) | ||
PJ Chief Executive Officer | Chief Executive Officer | 2013 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of REDEFINE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petra Johanna Kouri Eckmann | Chief Executive Officer | 0 companies |
| Kenneth Eckmann | Deputy Member | 0 companies |
| Petra Johanna Eckmann | Chief Executive Officer | 0 companies |